Stanislaw R. Burzynski, MD, PhD

biological therapy

antineoplaston A10

complementary and alternative therapy

biologically based therapies

alternative product therapy

cancer prevention intervention

differentiation therapy

A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG)

+13 more interventions

21 unique interventions3 categories

Analytics

Trial Phases

Phase 260

Phase 32

Trial Status

Completed12

Terminated38

Other12

Role Distribution

Principal Investigator53

Other Roles9

PI Rate85%

Activity Timeline

Clinical Trials (20)

NCT02742883Phase 2Suspended

Diffuse, Intrinsic Pontine Glioma

PrincipalinvestigatorStart date: 2016-04-13

NCT00003512Phase 2Withdrawn

Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia

Waldenstrom Macroglobulinemia

PrincipalinvestigatorStart date: 1999-02-18

NCT00003498Phase 2Terminated

Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma

Non Hodgkin Lymphoma

PrincipalinvestigatorStart date: 1997-10-13

NCT00003522Phase 2Terminated

Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine

Small Intestine Cancer

PrincipalinvestigatorStart date: 1997-08-13

NCT00003513Phase 2Terminated

Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma

Neuroblastoma

PrincipalinvestigatorStart date: 1996-12-16

NCT00003515Phase 2Terminated

Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Primitive Neuroectodermal Tumors

Primitive Neuroectodermal Tumor

PrincipalinvestigatorStart date: 1996-12-12

NCT00003534Phase 2Withdrawn

Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer

Stage IV Prostate Cancer

PrincipalinvestigatorStart date: 1996-10-11

NCT00003524Phase 2Terminated

Antineoplaston Therapy in Treating Patients With Stomach Cancer

Stomach (Gastric) Cancer

PrincipalinvestigatorStart date: 1996-10-04

NCT00003497Phase 2Terminated

Antineoplaston Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

Stage IV Non-small Cell Lung Cancer

PrincipalinvestigatorStart date: 1996-08-21

NCT00003521Phase 2Terminated

Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma

Soft Tissue Sarcoma

PrincipalinvestigatorStart date: 1996-06-14

Showing 10 of 20 trials

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Lymphoma, Non-Hodgkin3 Stage IV Breast Cancer3 Stage IV Lung Cancer3 Brain Stem Glioma2 Recurrent Breast Cancer2 Stage IV Prostate Cancer2 Adenocarcinoma of the Colon1 Adenocarcinoma of the Prostate1

Affiliations

Burzynski Research Institute

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Michael B Gill

Power Life Sciences Inc.

105 trials

Shared therapeutic areas:

Cancer of ColonCancer of Head and NeckCarcinoma, Merkel Cell+6 more

Similarity Score4%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

26 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinProstate CancerMultiple Myeloma+2 more

Similarity Score2%

Rahul Aggarwal, MD

University of California, San Francisco

22 trials

Shared therapeutic areas:

Prostate CancerMetastatic Prostate CancerStage IV Pancreatic Cancer+1 more

Similarity Score2%

Project Leader

Ono Pharmaceutical Co., Ltd.

47 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinPrimary Central Nervous System LymphomaRecurrent Breast Cancer+1 more

Similarity Score2%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

32 trials

Shared therapeutic areas:

Cancer of ColonMeningiomaMultiple Myeloma

NeuroblastomaSarcomaLymphoma, Non-Hodgkin

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

13 trials

Shared therapeutic areas:

Cancer of Head and NeckSarcomaStage IV Ovarian Cancer

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

21 trials

Shared therapeutic areas:

Mesothelioma, MalignantCancer of Colon

Sabine Hazan, MD

ProgenaBiome

41 trials

Shared therapeutic areas:

Multiple MyelomaLymphoma, Non-Hodgkin

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

24 trials

Shared therapeutic areas:

Prostate CancerCancer of Head and Neck

Aminah Jatoi, MD

Mayo Clinic

29 trials

Shared therapeutic areas: